As of 2026-09-23, the Relative Valuation of Treace Medical Concepts Inc (TMCI) is (27.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.59 USD, the upside of Treace Medical Concepts Inc based on Relative Valuation is -702.1%.
The range of the Relative Valuation is (28.61) - (27.63) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.2x - 37.2x | 34.6x |
| Forward P/E multiples | 22.9x - 30.1x | 25.6x |
| Fair Price | (28.61) - (27.63) | (27.64) |
| Upside | -723.2% - -702.0% | -702.1% |
| Date | P/E |
| 2026-09-22 | -5.00 |
| 2026-09-21 | -4.88 |
| 2026-09-18 | -4.89 |
| 2026-09-17 | -4.94 |
| 2026-09-16 | -4.97 |
| 2026-09-15 | -4.99 |
| 2026-09-14 | -5.05 |
| 2026-09-11 | -4.92 |
| 2026-09-10 | -4.74 |
| 2026-09-09 | -4.94 |
| 2026-09-08 | -5.05 |
| 2026-09-04 | -5.24 |
| 2026-09-03 | -5.32 |
| 2026-09-02 | -5.12 |
| 2026-09-01 | -5.01 |
| 2026-08-31 | -5.12 |
| 2026-08-28 | -5.07 |
| 2026-08-27 | -5.01 |
| 2026-08-26 | -5.14 |
| 2026-08-25 | -5.24 |
| 2026-08-24 | -4.76 |
| 2026-08-21 | -4.73 |
| 2026-08-20 | -4.86 |
| 2026-08-19 | -4.97 |
| 2026-08-18 | -4.85 |
| 2026-08-17 | -4.90 |
| 2026-08-14 | -5.22 |
| 2026-08-13 | -4.92 |
| 2026-08-12 | -5.18 |
| 2026-08-11 | -5.17 |
| 2026-08-10 | -5.09 |
| 2026-08-07 | -5.19 |
| 2026-08-06 | -4.77 |
| 2026-08-05 | -5.21 |
| 2026-08-04 | -5.17 |
| 2026-08-03 | -5.10 |
| 2026-07-31 | -4.70 |
| 2026-07-30 | -4.77 |
| 2026-07-29 | -4.40 |
| 2026-07-28 | -4.37 |
| 2026-07-27 | -4.45 |
| 2026-07-24 | -4.36 |
| 2026-07-23 | -4.41 |
| 2026-07-22 | -4.33 |
| 2026-07-21 | -4.61 |
| 2026-07-20 | -4.61 |
| 2026-07-17 | -4.69 |
| 2026-07-16 | -4.83 |
| 2026-07-15 | -4.80 |
| 2026-07-14 | -4.84 |